Technology in Diabetes Treatment: Update and Future

Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new tec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Artificial organs 2018-11, Vol.42 (11), p.1017-1027
Hauptverfasser: Schiel, Ralf, Bambauer, Rolf, Steveling, Antje
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1027
container_issue 11
container_start_page 1017
container_title Artificial organs
container_volume 42
creator Schiel, Ralf
Bambauer, Rolf
Steveling, Antje
description Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.
doi_str_mv 10.1111/aor.13296
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2122578236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2137405709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</originalsourceid><addsrcrecordid>eNp1kM1Kw0AURgdRbK0ufAEJuNFF2vlPxl2pVoVCQSK4GyaTW01JkzqTIH17p0ZdCN7N3RwOHwehc4LHJNzENG5MGFXyAA2JoCImQvFDNMRE4lhI_jJAJ96vMcYJx_IYDRhmjIuUDhHLwL7VTdW87qKyjm5Lk0MLPsocmHYDdXsTPW8L00Jk6iKad23n4BQdrUzl4ez7j1A2v8tmD_Fief84my5iywSTMVE5XbEC0jylkhkVNmFQAueGW6sKyyVJWGEKwBYwSzinkKRE5FJJbJliI3TVa7euee_At3pTegtVZWpoOq8poVQkKWUyoJd_0HXTuTqMC1RQY5HgvfC6p6xrvHew0ltXbozbaYL1PqQOIfVXyMBefBu7fAPFL_lTLgCTHvgoK9j9b9LT5VOv_AT4uHnb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2137405709</pqid></control><display><type>article</type><title>Technology in Diabetes Treatment: Update and Future</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schiel, Ralf ; Bambauer, Rolf ; Steveling, Antje</creator><creatorcontrib>Schiel, Ralf ; Bambauer, Rolf ; Steveling, Antje</creatorcontrib><description>Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.</description><identifier>ISSN: 0160-564X</identifier><identifier>EISSN: 1525-1594</identifier><identifier>DOI: 10.1111/aor.13296</identifier><identifier>PMID: 30334582</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Blood Glucose - analysis ; Blood Glucose Self-Monitoring - methods ; Calculators ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus - blood ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - therapy ; Disease control ; Glucose ; Glucose monitoring ; HbA1c ; Hemoglobin ; Humans ; Hypoglycemia ; Hypoglycemic Agents - administration &amp; dosage ; Hypoglycemic Agents - therapeutic use ; Infusions, Subcutaneous ; Insulin ; Insulin - administration &amp; dosage ; Insulin - therapeutic use ; Monitoring ; New technology ; Patient Education as Topic ; Patients ; pump ; Upgrading</subject><ispartof>Artificial organs, 2018-11, Vol.42 (11), p.1017-1027</ispartof><rights>2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.</rights><rights>Copyright © 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</citedby><cites>FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</cites><orcidid>0000-0002-4115-436X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Faor.13296$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Faor.13296$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30334582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schiel, Ralf</creatorcontrib><creatorcontrib>Bambauer, Rolf</creatorcontrib><creatorcontrib>Steveling, Antje</creatorcontrib><title>Technology in Diabetes Treatment: Update and Future</title><title>Artificial organs</title><addtitle>Artif Organs</addtitle><description>Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.</description><subject>Animals</subject><subject>Blood Glucose - analysis</subject><subject>Blood Glucose Self-Monitoring - methods</subject><subject>Calculators</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - therapy</subject><subject>Disease control</subject><subject>Glucose</subject><subject>Glucose monitoring</subject><subject>HbA1c</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Hypoglycemic Agents - administration &amp; dosage</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Infusions, Subcutaneous</subject><subject>Insulin</subject><subject>Insulin - administration &amp; dosage</subject><subject>Insulin - therapeutic use</subject><subject>Monitoring</subject><subject>New technology</subject><subject>Patient Education as Topic</subject><subject>Patients</subject><subject>pump</subject><subject>Upgrading</subject><issn>0160-564X</issn><issn>1525-1594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1Kw0AURgdRbK0ufAEJuNFF2vlPxl2pVoVCQSK4GyaTW01JkzqTIH17p0ZdCN7N3RwOHwehc4LHJNzENG5MGFXyAA2JoCImQvFDNMRE4lhI_jJAJ96vMcYJx_IYDRhmjIuUDhHLwL7VTdW87qKyjm5Lk0MLPsocmHYDdXsTPW8L00Jk6iKad23n4BQdrUzl4ez7j1A2v8tmD_Fief84my5iywSTMVE5XbEC0jylkhkVNmFQAueGW6sKyyVJWGEKwBYwSzinkKRE5FJJbJliI3TVa7euee_At3pTegtVZWpoOq8poVQkKWUyoJd_0HXTuTqMC1RQY5HgvfC6p6xrvHew0ltXbozbaYL1PqQOIfVXyMBefBu7fAPFL_lTLgCTHvgoK9j9b9LT5VOv_AT4uHnb</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Schiel, Ralf</creator><creator>Bambauer, Rolf</creator><creator>Steveling, Antje</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4115-436X</orcidid></search><sort><creationdate>201811</creationdate><title>Technology in Diabetes Treatment: Update and Future</title><author>Schiel, Ralf ; Bambauer, Rolf ; Steveling, Antje</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Blood Glucose - analysis</topic><topic>Blood Glucose Self-Monitoring - methods</topic><topic>Calculators</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - therapy</topic><topic>Disease control</topic><topic>Glucose</topic><topic>Glucose monitoring</topic><topic>HbA1c</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Hypoglycemic Agents - administration &amp; dosage</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Infusions, Subcutaneous</topic><topic>Insulin</topic><topic>Insulin - administration &amp; dosage</topic><topic>Insulin - therapeutic use</topic><topic>Monitoring</topic><topic>New technology</topic><topic>Patient Education as Topic</topic><topic>Patients</topic><topic>pump</topic><topic>Upgrading</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schiel, Ralf</creatorcontrib><creatorcontrib>Bambauer, Rolf</creatorcontrib><creatorcontrib>Steveling, Antje</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schiel, Ralf</au><au>Bambauer, Rolf</au><au>Steveling, Antje</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Technology in Diabetes Treatment: Update and Future</atitle><jtitle>Artificial organs</jtitle><addtitle>Artif Organs</addtitle><date>2018-11</date><risdate>2018</risdate><volume>42</volume><issue>11</issue><spage>1017</spage><epage>1027</epage><pages>1017-1027</pages><issn>0160-564X</issn><eissn>1525-1594</eissn><abstract>Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30334582</pmid><doi>10.1111/aor.13296</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-4115-436X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0160-564X
ispartof Artificial organs, 2018-11, Vol.42 (11), p.1017-1027
issn 0160-564X
1525-1594
language eng
recordid cdi_proquest_miscellaneous_2122578236
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Blood Glucose - analysis
Blood Glucose Self-Monitoring - methods
Calculators
Diabetes
Diabetes mellitus
Diabetes Mellitus - blood
Diabetes Mellitus - epidemiology
Diabetes Mellitus - therapy
Disease control
Glucose
Glucose monitoring
HbA1c
Hemoglobin
Humans
Hypoglycemia
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - therapeutic use
Infusions, Subcutaneous
Insulin
Insulin - administration & dosage
Insulin - therapeutic use
Monitoring
New technology
Patient Education as Topic
Patients
pump
Upgrading
title Technology in Diabetes Treatment: Update and Future
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T00%3A59%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Technology%20in%20Diabetes%20Treatment:%20Update%20and%20Future&rft.jtitle=Artificial%20organs&rft.au=Schiel,%20Ralf&rft.date=2018-11&rft.volume=42&rft.issue=11&rft.spage=1017&rft.epage=1027&rft.pages=1017-1027&rft.issn=0160-564X&rft.eissn=1525-1594&rft_id=info:doi/10.1111/aor.13296&rft_dat=%3Cproquest_cross%3E2137405709%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2137405709&rft_id=info:pmid/30334582&rfr_iscdi=true